<DOC>
	<DOCNO>NCT01666886</DOCNO>
	<brief_summary>In protocol `` Predicting therapeutic outcome mandibular advancement device treatment obstructive sleep apnea ( PROMAD ) '' , 100 patient obstructive sleep apnea include started MAD treatment 75 % maximal protrusion . All patient underwent polysomnography MAD situ evaluate effect MAD severity sleep apnea . If result polysomnography MAD unsuccessful ( define reduction AHI MAD situ less 50 % compare baseline ) , therapy need adjust . Finding effective protrusion weight compromise efficacy side-effects MAD therapy . In patient insufficient result polysomnography MAD 75 % maximal protrusion , MAD adjust 90 % maximal protrusion measure follow-up visit polysomnography MAD . After habituation adaptation period within 2 month first polysomnography MAD , new polysomnography perform assess effect 90 % protruded position .</brief_summary>
	<brief_title>Efficacy Additional Titration During Oral Appliance Treatment Sleep-disordered Breathing .</brief_title>
	<detailed_description />
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<criteria>Age ≥ 18 year Body Mass Index ( BMI ) ≤ 35 kg/m² OSAS , define American Academy Sleep Medicine Task Force apneahypopnea index ( AHI ) &lt; 50 incomplete elimination apnea and/or hypopnea therapy mandibular advancement device 75 % maximal protrusion Other sleep disorder ( i.e . parasomnias ) Invasive upper airway surgery sleepdisordered breathe Known genetic disorder craniofacial and/or upper airway malformation Use benzodiazepine and/or antidepressant Known history psychiatric disease Known history fibromyalgia and/or chronic fatigue syndrome Dental contraindication : functional restriction temporomandibular joint , insufficient dentition pathological change , insufficient retention MAD use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>